Biomarkers of oxidative damage are elevated among individuals with high cardiovascular risk: Refining subject selection strategies for antioxidant trials

References

• Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, . Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995;91: 2488–2496.
   PubMed Web of Science ®Google Scholar
• Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7A–11A.
   PubMed Web of Science ®Google Scholar
• Praticò D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, . Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 1997;100: 2028–2034.
   PubMed Web of Science ®Google Scholar
• Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 1994;94:877–884.
   PubMedGoogle Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473: 317–325.
   PubMed Web of Science ®Google Scholar
• Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996;64:190–196.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450–1456.
   PubMed Web of Science ®Google Scholar
• Lönn ME, Dennis JM, Stocker R. Actions of “antioxidants” in the protection against atherosclerosis. Free Radic Biol Med 2012;53:863–884.
   PubMed Web of Science ®Google Scholar
• Sugamura K, Keaney JF Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 2011;51:978–992.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012;70:257–265.
   PubMed Web of Science ®Google Scholar
• Patrignani P, Panara MR, Tacconelli S, Seta F, Bucciarelli T, Ciabattoni G, . Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 2000;102:539–545.
   PubMed Web of Science ®Google Scholar
• Keaney JF Jr , Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, ; Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23: 434–439.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Lee CY. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signal 2010;13:145–156.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383–9387.
   PubMed Web of Science ®Google Scholar
• Seet RC, Lee CY, Chan BP, Sharma VK, Teoh HL, Venketasubramanian N, . Oxidative damage in ischemic stroke revealed using multiple biomarkers. Stroke 2011; 42:2326–2329.
   PubMedGoogle Scholar
• Seet RC, Lee CY, Lim EC, Quek AM, Huang H, Huang SH, . Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis 2011;219:231–239.
   PubMed Web of Science ®Google Scholar
• Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, . Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004;109:843–848.
   PubMed Web of Science ®Google Scholar
• Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 1998;4:1189–1192.
   PubMed Web of Science ®Google Scholar
• Tangirala RK, Praticó D, FitzGerald GA, Chun S, Tsukamoto K, Maugeais C, . Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 2001;276:261–266.
   PubMedGoogle Scholar
• Seet RC, Lee CY, Lim EC, Quek AM, Huang SH, Khoo CM, Halliwell B. Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. Diabetes Care 2010;33:1140–1142.
   PubMedGoogle Scholar
• Barden AE, Corcoran TB, Mas E, Durand T, Galano JM, Roberts LJ, . Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?Antioxid Redox Signal 2012;16:165–169.
   PubMed Web of Science ®Google Scholar
• Prunet C, Petit JM, Ecarnot-Laubriet A, Athias A, Miguet-Alfonsi C, Rohmer JF, . High circulating levels of 7beta- and 7alpha-hydroxycholesterol and presence of apoptotic and oxidative markers in arterial lesions of normocholesterolemic atherosclerotic patients undergoing endarterectomy. Pathol Biol 2006;54:22–32.
   PubMed Web of Science ®Google Scholar
• Alkazemi D, Egeland G, Vaya J, Meltzer S, Kubow S. Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrin Metab 2008;93:4282–4289.
   PubMedGoogle Scholar
• Shentu TP, Singh DK, Oh MJ, Sun S, Sadaat L, Makino A, . The role of oxysterols in control of endothelial stiffness. J Lipid Res 2012;53:1348–1358.
   PubMedGoogle Scholar
• Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, . Gamma-glutamyltransferase and diabetes–a 4 year follow-up study. Diabetologia 2003;46:359–364.
   PubMed Web of Science ®Google Scholar
• Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998;21:732–737.
   PubMed Web of Science ®Google Scholar
• Lee DH, Ha MH, Kim JR, Gross M, Jacobs DR Jr. Gamma-glutamyltransferase, alcohol, and blood pressure. A four year follow-up study. Ann Epidemiol 2002;12:90–96.
   PubMed Web of Science ®Google Scholar
• Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000;248:230–238.
   PubMed Web of Science ®Google Scholar
• Seet RC, Lee CY, Loke WM, Huang SH, Huang H, Looi WF, . Biomarkers of oxidative damage in cigarette smokers: Which biomarkers might reflect acute versus chronic oxidative stress?Free Radic Biol Med 2011;50:1787–1793.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB Sr.,Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation 2009; 119:3078–3084.
   PubMed Web of Science ®Google Scholar
• Musiek ES, Cha JK, Yin H, Zackert WE, Terry ES, Porter NA, . Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J Chromatogr B Analyt Technol Biomed Life Sci 2004;799:95–102.
   PubMed Web of Science ®Google Scholar
• Lee CY, Huang SH, Jenner AM, Halliwell B. Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample. Free Radic Biol Med 2008;44:1314–1322.
   PubMed Web of Science ®Google Scholar
• Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 2012; 107:S201–213.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747–2757.
   PubMed Web of Science ®Google Scholar
• Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, . Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009;119:902–907.
   PubMed Web of Science ®Google Scholar
• Swann PG, Venton DL, Le Breton GC. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett 1989;243:244–246.
   PubMed Web of Science ®Google Scholar
• Gaudette DC, Holub BJ. Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity. Lipids 1990;25:166–169.
   PubMed Web of Science ®Google Scholar
• Chen MF, Hsu HC, Chen WJ, Lee CM, Wu CC, Liau CS, Lee YT. Fish oil supplementation attenuates free radical generation in short-term coronary occlusion-reperfusion in cholesterol-fed rabbits. Prostaglandins 1994;47:307–317.
   PubMedGoogle Scholar
• Bjorkhem I, Reihner E, Angelin B, Ewerth S, Akerlund JE, Einarsson K. On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J Lipid Res 1987;28:889–894.
   PubMed Web of Science ®Google Scholar
• Karp DR, Shimooku K, Lipsky PE. Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 2001;276: 3798–3804.
   PubMed Web of Science ®Google Scholar
• Hanigan MH, Ricketts WA. Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 1993;32:6302–6306.
   PubMed Web of Science ®Google Scholar
• Hochwald SN, Harrison LE, Rose DM, Anderson M, Burt ME. Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst 1996;88: 193–197.
   PubMed Web of Science ®Google Scholar
• Wannamethee G, Ebrahim S, Shaper AG. Gamma- glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699–708.
   PubMed Web of Science ®Google Scholar
• Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, . Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127–133.
   PubMed Web of Science ®Google Scholar
• Emdin M, Passino C, Michelassi C, Titta F, L'abbate A, Donato L, . Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001;22:1802–7.
   PubMed Web of Science ®Google Scholar
• Karlson BW, Wiklund O, Hallgren P, Sjolin M, Lindqvist J, Herlitz J. Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 2000;247:449–456.
   PubMed Web of Science ®Google Scholar
• Eisenhardt SU, Habersberger J, Peter K. Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk. Trends Cardiovasc Med 2009;19:232–237.
   PubMedGoogle Scholar
• Roman RJ, Renic M, Dunn KM, Takeuchi K, Hacein-Bey L. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm. Neurol Res 2006; 28:738–749.
   PubMed Web of Science ®Google Scholar
• Ward NC, Rivera J, Hodgson J, Puddey IB, Beilin LJ, Falck JR, Croft KD. Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans. Circulation 2004;110:438–443.
   PubMed Web of Science ®Google Scholar
• Shishehbor MH, Zhang R, Medina H, Brennan ML, Brennan DM, Ellis SG, . Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic Biol Med 2006;41:1678–1683.
   PubMed Web of Science ®Google Scholar